| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.0054 | 1 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |